299. Cystic fibrosis Clinical trials / Disease details
Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02605538 (ClinicalTrials.gov) | September 1, 2015 | 4/5/2015 | Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively | Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively | Cystic Fibrosis;Hepatitis A;Hepatitis B;Tuberculosis | Biological: Vaccination with vaccine against hepatitis A and B | Karolinska University Hospital | Karolinska Institutet | Enrolling by invitation | 1 Year | N/A | All | 250 | N/A | Sweden |